You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API levonorgestrel and ethinyl estradiol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing levonorgestrel and ethinyl estradiol

Company Ingredient NDC Excipient
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472 LACTOSE MONOHYDRATE
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472 MAGNESIUM STEARATE
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472 POVIDONE K30
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 0591-0295 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 0591-0295 CROSCARMELLOSE SODIUM
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for levonorgestrel and ethinyl estradiol

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYPROMELLOSE

Excipient focus: LACTOSE MONOHYDRATE

levonorgestrel and ethinyl estradiol drug variants containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 0591-0295
Ingenus Pharmaceuticals LLC levonorgestrel and ethinyl estradiol 50742-659
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 52544-295
Glenmark Pharmaceuticals Inc USA levonorgestrel and ethinyl estradiol 68462-637
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

levonorgestrel and ethinyl estradiol drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
Teva Pharmaceuticals Inc levonorgestrel and ethinyl estradiol 0480-3472
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 0591-0295
Ingenus Pharmaceuticals LLC levonorgestrel and ethinyl estradiol 50742-659
Actavis Pharma Inc levonorgestrel and ethinyl estradiol 52544-295
Glenmark Pharmaceuticals Inc USA levonorgestrel and ethinyl estradiol 68462-637
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links